OpenVSafe by OpenVAERS
Search V-safe

JFB-26550-80918

2 vaccinations 2 coded responses 2 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
605 / IL
Registered
2022-01-28
Relationship
Child or adolescent in my care
Guardian
DSC-14278-28839
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-11
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-04
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-28
    Registered in v-safe
  4. 2022-03-05
    Survey response — 3 months, dose 2, dependent
    MedDRA: COVID-19, Nasopharyngitis — Feeling: Good · Be unable to work or attend school
    Free text: Miles developed COVID and had cold-like symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-06-04
    Survey response — 6 months, dose 2, dependent
    MedDRA: Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good
    Free text: Miles had cold-like symptoms (sniffles/runny nose), but he was negative for COVID.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-11Pfizer-BioNTech No
22021-12-04Pfizer-BioNTech No

Free text

Release 11 — 3 months, dose 2, dependent

2022-03-05

Symptoms: Miles developed COVID and had cold-like symptoms.

Release 11 — 6 months, dose 2, dependent

2022-06-04

Symptoms: Miles had cold-like symptoms (sniffles/runny nose), but he was negative for COVID.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release